Managing the child with fever and neutropenia in an era of increasing microbial resistance

Journal of Pediatrics

Volumn 140, Issue 1, 2002, Pages 5-7

  Haslam, David B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; BACTERIUM ISOLATE; BLOOD CULTURE; EDITORIAL; FEVER; HUMAN; LYMPHOMA; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEPTICEMIA;

EID: 0036159205     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.120266     Document Type: Article

References (13)

1. PA. Pizzo Fever in immunocompromised patients N Engl J Med 341 1999 893 900
2. WT Hughes D Armstrong GP Bodey AE Brown JE Edwards R Feld 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever: Infectious Diseases Society of America Clin Infect Dis 25 1997 551 573
3. LB Bruckner DN Korones T Karnauchow DJ Hardy F. Gigliotti High incidence of penicillin resistance among α-hemolytic streptococci isolated from the blood of children with cancer J Pediatr 140 2002 20 26
4. B Koll A. Brown The changing epidemiology of infections at cancer hospitals Clin Infect Dis 17 2 Suppl 1993 S322 S328
5. H Wisplinghoff RR Reinert O Cornely H. Seifert Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients J Clin Microbiol 37 1999 1876 1880
6. LS Elting GP Bodey BH. Keefe Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors Clin Infect Dis 14 1992 1201 1207
7. A Marron J Carratala F Alcaide A Fernandez-Sevilla F. Gudiol High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients J Antimicrob Chemother 47 2001 87 91
8. F Alcaide J Carratala J Linares F Guidol R. Martin In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients Antimicrob Agents Chemother 40 1996 2117 2120
9. RR Reinert C von Eiff M Kresken J Brauers D Hafner A Al-Lahham Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight ether antimicrobials J Clin Microbiol 39 2001 1928 1931
10. JL Shenep WT Hughes PK Roberson KR Blankenship DK Baker WH Meyer Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer N Engl J Med 319 1988 1053 1058
11. European Organization for Research and Treatment of Cancer EORTC International Antimicrobial Therapy Cooperative Group, National Cancer Institute of Canada—Clinical Trials Group Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients J Infect Dis 163 1991 951 958
12. A Roguin I Kasis MW Ben-Arush R Sharon M. Berant Fever and neutropenia in children with malignant disease Pediatr Hematol Oncol 13 1996 503 510
13. A Marron J Carratala E Gonzalez-Barca A Fernandez-Sevilla F Alcaide F. Guidol Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer Clin Infect Dis 31 2000 1126 1130